Stay updated on Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Results have been posted for the Ramucirumab + Pembrolizumab trial (Phase I/II), including RP2D details, endpoints, adverse events, and quality-of-life measures. The update also includes follow-up timelines and related documentation.
    Difference
    6%
    Check dated 2026-08-22T21:43:39.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a small update to the page's versioning without altering the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T18:02:33.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision stamp was updated from v3.6.3 to v3.6.4, signaling an update to the page. This reflects a version bump rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-07-25T10:24:53.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision is updated from v3.6.2 to v3.6.3, indicating a new revision of the study entry. This appears to be a metadata update rather than a change to study content or trial details.
    Difference
    0.1%
    Check dated 2026-07-03T22:53:33.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.6.2 has been added, replacing the previous v3.6.0; this represents a page template update and does not modify the study content.
    Difference
    0.1%
    Check dated 2026-06-27T01:47:53.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page now displays that the study is no longer enrolling participants and that results have been submitted. It also adds new navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label (from 'Intervention / Treatment' to 'Intervention/Treatment') with a revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:59:53.000Z thumbnail image

Stay in the know with updates to Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.